Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

IMV Inc. (IMV)

0.7379   0.043 (6.2%) 06-26 19:48
Open: 0.71 Pre. Close: 0.6948
High: 0.7389 Low: 0.69
Volume: 61,933 Market Cap: 61(M)
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.74 - 0.74 0.74 - 0.75
Low: 0.68 - 0.69 0.69 - 0.69
Close: 0.73 - 0.74 0.74 - 0.74

Technical analysis

as of: 2022-06-24 4:40:51 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 1.01     One year: 1.23
Support: Support1: 0.56    Support2: 0.46
Resistance: Resistance1: 0.86    Resistance2: 1.05
Pivot: 0.75
Moving Average: MA(5): 0.68     MA(20): 0.79
MA(100): 1.14     MA(250): 1.39
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 41.3     %D(3): 35.5
RSI: RSI(14): 41
52-week: High: 2.41  Low: 0.56
Average Vol(K): 3-Month: 76 (K)  10-Days: 103 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ IMV ] has closed above bottom band by 45.2%. Bollinger Bands are 40.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.

Headline News

Wed, 22 Jun 2022
IMV Strengthens Its Financial Position With the $US10 Million Drawdown From Its Existing Long-Term Debt Facility - Business Wire

Tue, 21 Jun 2022
In Covid-19, We Looked At the Mortality Differences Between Acute Respiratory Failure Management Strategies. - Physician's Weekly

Mon, 20 Jun 2022
mRNA Vaccines Prevent COVID-19-Associated IMV, Death - Medscape

Mon, 20 Jun 2022
ImminentVerse (IMV), High Volatility and Falling Monday: Is it Time to Cash Out? - InvestorsObserver

Fri, 17 Jun 2022
Dexamethasone Increases Risk for Superinfections in Patients With Severe COVID-19 - Infectious Disease Advisor

Thu, 16 Jun 2022
IMV (TSE:IMV) Sets New 12-Month Low at $0.91 - Defense World

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 82 (M)
% Held by Insiders 7.55e+007 (%)
% Held by Institutions 0.6 (%)
Shares Short 840 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -3.878e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -20
Return on Assets (ttm) 797.8
Return on Equity (ttm) -50.9
Qtrly Rev. Growth 188000
Gross Profit (p.s.) 0
Sales Per Share -74.76
EBITDA (p.s.) -1.23422e+007
Qtrly Earnings Growth -0.5
Operating Cash Flow 0 (M)
Levered Free Cash Flow -32 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.01
Price to Cash Flow 3.44

Stock Dividends

Dividend 0
Forward Dividend 799360
Dividend Yield 0%
Dividend Pay Date 2018-05-09
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.